BIO-TECHNE Corp·4

Oct 28, 5:05 PM ET

WIENS HAROLD J 4

4 · BIO-TECHNE Corp · Filed Oct 28, 2019

Insider Transaction Report

Form 4
Period: 2019-10-24
Transactions
  • Award

    Common Stock

    2019-10-24+4955,221 total
  • Award

    Stock Option (right to buy)

    2019-10-24+2,0112,011 total
    Exercise: $201.64Exp: 2029-10-24Common Stock (2,011 underlying)
Holdings
  • Stock Option (right to buy)

    Exercise: $87.83From: 2014-05-15Exp: 2024-05-15Common Stock (2,000 underlying)
    2,000
  • Stock Option (right to buy)

    Exercise: $87.34From: 2016-10-29Exp: 2025-10-28Common Stock (4,260 underlying)
    4,260
  • Stock Option (right to buy)

    Exercise: $91.78From: 2014-10-30Exp: 2024-10-30Common Stock (4,000 underlying)
    4,000
  • Stock Option (right to buy)

    Exercise: $179.84From: 2019-10-24Exp: 2028-10-25Common Stock (1,898 underlying)
    1,898
  • Stock Option (right to buy)

    Exercise: $101.19From: 2017-10-26Exp: 2026-10-26Common Stock (3,985 underlying)
    3,985
  • Stock Option (right to buy)

    Exercise: $125.05From: 2018-10-25Exp: 2027-10-26Common Stock (3,125 underlying)
    3,125
Footnotes (1)
  • [F1]The option vests on the earlier of the one year anniversary of the grant date (10/24/2019) or the date of Bio-Techne's 2020 annual meeting of shareholders.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT